Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract

J Histochem Cytochem. 2000 May;48(5):603-11. doi: 10.1177/002215540004800504.

Abstract

We investigated the spatiotemporal distributions of the different peroxisome proliferator-activated receptor (PPAR) isotypes (alpha, beta, and gamma) during development (Week 7 to Week 22 of gestation) of the human fetal digestive tract by immunohistochemistry using specific polyclonal antibodies. The PPAR subtypes, including PPARgamma, are expressed as early as 7 weeks of development in cell types of endodermal and mesodermal origin. The presence of PPARgamma was also found by Western blotting and nuclease-S1 protection assay, confirming that this subtype is not adipocyte-specific. PPARalpha, PPARbeta, and PPARgamma exhibit different patterns of expression during morphogenesis of the digestive tract. Whatever the stage and the gut region (except the stomach) examined, PPARgamma is expressed at a high level, suggesting some fundamental role for this receptor in development and/or physiology of the human digestive tract.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Specificity
  • Blotting, Western
  • Cell Differentiation
  • Cell Nucleus / metabolism
  • Colon / cytology
  • Colon / embryology
  • Colon / metabolism
  • Cytoplasm / metabolism
  • Digestive System / cytology
  • Digestive System / embryology*
  • Digestive System / metabolism*
  • Esophagus / cytology
  • Esophagus / embryology
  • Esophagus / metabolism
  • Gastric Mucosa / metabolism
  • Humans
  • Intestine, Small / cytology
  • Intestine, Small / embryology
  • Intestine, Small / metabolism
  • Receptors, Cytoplasmic and Nuclear / biosynthesis*
  • Stomach / cytology
  • Stomach / embryology
  • Transcription Factors / biosynthesis*

Substances

  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors